Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -38.46% and 5.03%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of -2.08% and 6.92%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Shareholder rights law firm Robbins LLP is investigating Talis Biomedical Corporation (NASDAQ: TLIS) to determine whether certain Talis officers and directors violated securities laws and breached fiduciary...
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific...
TLIS earnings call for the period ending March 31, 2022.
Clene Inc. (CLNN) delivered earnings and revenue surprises of -16.67% and 76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
MannKind (MNKD) delivered earnings and revenue surprises of 0% and 14.91%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
MENLO PARK, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes...
TLIS earnings call for the period ending December 31, 2021.
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific...